Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Ocular Hypertension Clinical Trials

13 recruiting trials for Ocular Hypertension. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
13
Total Trials
13
Recruiting Now
2
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 1NCT07036510

Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract...

The goal of this clinical trial is to test a new method to deliver an approved medicine called Timolol in the eye of participants with glaucoma or ocular hypertension and...

Sponsor: EyeD PharmaEnrolling: 181 location
RECRUITINGPhase 4NCT07217678

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduction in ocular...

Sponsor: University of MiamiEnrolling: 201 location
RECRUITINGPhase 2NCT06964191

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

The goal of this clinical trial is to determine the dose of PA5108 Ocular Implant that is effective and safe for the reduction of intraocular pressure in adult patients with...

Sponsor: PolyActiva Pty LtdEnrolling: 751 location
RECRUITINGPhase 3NCT07335211

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma...

Sponsor: Huons Co., Ltd.Enrolling: 2061 location
RECRUITINGNCT05039684

Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical...

Glaucoma is a chronic optic neuropathy whose main modifiable risk factor is an abnormally elevated intraocular pressure. The aim of glaucoma treatment is to slow the progression...

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBAEnrolling: 401 location
RECRUITINGNCT05902871

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Primary Open Angle...

Sponsor: BelkinVisionEnrolling: 452 locations
RECRUITINGPhase 3NCT07218796

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL...

This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to...

Sponsor: SpyGlass Pharma, Inc.Enrolling: 4001 location
RECRUITINGNCT06691555

Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt

The goal of this observational study is to evaluate the long-term safety and efficacy of a modified suprachoroidal silicone tube (SST) shunt in treating patients with primary...

Sponsor: Davinci LTDEnrolling: 661 location
RECRUITINGNCT05844384

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical...

Sponsor: 59th Medical WingEnrolling: 301 location
RECRUITINGPhase 4NCT07325240

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

The purpose of this study is to evaluate the effect on 24-hour IOP reduction of netarsudil-latanoprost fixed combination in one eye compared to latanoprost alone in the...

Sponsor: Mayo ClinicEnrolling: 301 location
RECRUITINGNCT07119580

Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma

Background Intact corneal epithelium is important for the defense on the ocular surface, and the function of limbal stem cells is crucial to maintain its integrity. Certain...

Sponsor: National Taiwan University HospitalEnrolling: 901 location
RECRUITINGPhase 1NCT06267274

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical...

A randomized, double-blind, parallel-group, two-arm, multiple dose, multicenter, clinical endpoint bioequivalence study

Sponsor: Amneal Pharmaceuticals, LLCEnrolling: 2404 locations
RECRUITINGNCT06629649

Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers

The goal of this clinical trial is to learn if implementation of an eye screening program at Federally Qualified Health Center (FQHC) clinics provides results that participants...

Sponsor: University of Alabama at BirminghamEnrolling: 18001 location